Influence of genotype, viral load and fibrosis on the sustained virologic response rate to pegylated interferon alpha-2a plus ribavirin, with or without amantadine, in chronic hepatitis C patients non-responders to alpha interferferon plus ribavirin

被引：0
|
作者：
Cheinquer, H.
Pessoa, M.
Sette, H., Jr.
Parise, E.
Parana, R.
Tatsch, F.
机构：
[1] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[2] Hosp Emilio Ribas, Sao Paulo, Brazil
[3] Pro Figado, Gastroenterol & Hepatol, Sao Paulo, Brazil
[4] Univ Fed Sao Paulo, Sao Paulo, Brazil
[5] Univ Fed Bahia, Salvador, BA, Brazil
[6] Roche, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL VIROLOGY | 2006年 / 36卷
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
下载
收藏
页码：S147 / S147
页数：1
相关论文
共 50 条
  • [1] Influence of genotype, viral load and fibrosis on the sustained virologic response rate to pegylated interferon alpha-2a plus ribavirin, with or without amantadine, in chronic hepatitis C patients relapsers to alpha interferferon plus ribavirin
    Cheinquer, H.
    Sette, H., Jr.
    Pessoa, M.
    Parana, R.
    Parise, E.
    Tatsch, F.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S147 - S148
  • [2] Induction treatment of chronic hepatitis C with daily interferon plus ribavirin plus amantadine is effective in non-responders to interferon plus ribavirin
    Stauber, R
    Munda-Steindl, P
    Hackl, F
    Schüutze, K
    Datz, C
    Hofer, H
    Hegenbarth, K
    Jessner, W
    Ferenci, P
    JOURNAL OF HEPATOLOGY, 2001, 34 : 134 - 135
  • [3] A randomised trial of pegylated interferon alpha-2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin
    Ciancio, A.
    Picciotto, A.
    Giordanino, C.
    Smedile, A.
    Tabone, M.
    Manca, A.
    Marenco, G.
    Garbagnoli, P.
    Andreoni, M.
    Cariti, G.
    Calleri, G.
    Sartori, M.
    Cusumano, S.
    Grasso, A.
    Basso, M.
    Rizzetto, M.
    Saracco, G.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S148 - S148
  • [4] Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis
    Camma, Calogero
    Cabibbo, Giuseppe
    Bronte, Fabrizio
    Enea, Marco
    Licata, Anna
    Attanasio, Massimo
    Andriulli, Angelo
    Craxi, Antonio
    JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 675 - 681
  • [5] Prospective randomized study of peginterferon alpha-2a, ribavirin and amantadine vs peginterferon alpha-2a plus ribavirin, in hepatitis C patients now responders or relapsers to interferon-alpha and ribavirin
    Cheinquer, H.
    Pessoa, M.
    Almeida, P.
    Silva, G.
    Patelli, M.
    Parana, R.
    Parise, E.
    Lacerda, M.
    Pernambuco, J.
    Pedrosa, S.
    Teixeira, R.
    Tatsch, E.
    Sette, H.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S209 - S209
  • [6] Efficacy and tolerability of pegylated interferon alpha-2a plus ribavirin versus pegylated interferon alpha-2b plus ribavirin, in treatment naive chronic hepatitis C patients
    Lee, S. Y.
    Lee, S.
    Ko, K. S.
    Kim, I. H.
    Kim, S. H.
    Kim, S. W.
    Lee, S. O.
    Lee, S. T.
    Kim, D. G.
    Choi, C. S.
    Cho, E. Y.
    Kim, H. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A176 - A176
  • [7] Insulin resistance, fibrosis and genotype are predictors of sustained response rate to pegylated interferon plus ribavirin in patients with chronic hepatitis C
    Romero-Gomez, M
    Viloria, MM
    Corpas, R
    Cruz, M
    Sanchez-Munoz, D
    Grande, L
    Castillo, J
    Suarez, E
    Camacho, I
    Nogales, MC
    JOURNAL OF HEPATOLOGY, 2004, 40 : 150 - 150
  • [8] Early predictors of sustained viral response (SVR) in chronic hepatitis C (Genotype 4) patients treated with pegylated interferon alpha-2a and ribavirin
    Elmakhzangy, HI
    Rekacewicz, C
    Shouman, S
    Mohamed, HN
    Esmat, G
    Mansour, AA
    Ismail, A
    Rafaat, R
    Elhosseiny, M
    Eldaly, M
    Elkafrawy, S
    Abdel-Hamid, M
    Fontanet, A
    Pol, S
    Mohamed, MK
    GASTROENTEROLOGY, 2005, 128 (04) : A714 - A714
  • [9] Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C
    Di Bisceglie, A. M.
    Ghalib, R. H.
    Hamzeh, F. M.
    Rustgi, V. K.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (10) : 721 - 729
  • [10] The Retreatment of Genotype 4 Chronic Hepatitis C Patients with Pegylated Interferon Alpha-2a and Ribavirin
    Peedikayil, Musthafa
    Al Ashgar, Hamad
    Al Kahtani, Khalid
    Al Sohaibani, Fahad
    Ingvar, Kagevi
    Al Quaiz, Mohammed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S134 - S134
12345